Patients with cancer rarely make clinically inappropriate demands
the ONA take:
According to a new study published in the journal JAMA Oncology, researchers from Abramson Cancer Center and the University of Pennsylvania Perelman School of Medicine in Philadelphia, Pennsylvania, have found that patients rarely push for unnecessary tests and treatments despite physicians' claims that high medical costs are due to patient demands.
For the study, researchers analyzed over 5,000 patient-clinician encounters and found that 440 (8.7%) of those included a patient request or demand for a particular medical medical intervention. Of those, clinicians complied with 365 of the demands after deeming them clinically appropriate.
Of the 50 demands that were not clinically appropriate, clinicians only complied with seven demands. Results showed that 49.1% of demands were for imaging studies, 15.5% for palliative care interventions, 13.6% for laboratory tests, 5.2% for genetic tests, 3.6% for chemotherapy, and less than 1% for proton beam therapy.
In addition, researchers found that patients who had worse relationships with their clinicians and those actively receiving therapy were more likely to make requests or demands.
The findings suggest that patients demands are low and cannot be a key factor of increasing healthcare costs.
Patients rarely push for unnecessary tests and treatments despite physicians' claims that high medical costs are due to patient demands.
- Ixazomib, a New PI, Offers Improved Efficacy With Acceptable Toxicity Profile for Relapsed/Refractory Multiple Myeloma
- Acupuncture May Improve Fatigue in Patients with Lung Cancer
- A Review of CDK4/6 Toxicities and Interactions Management in Breast Cancer
- "Light" Cigarettes and Cancer Risk (Fact Sheet)
- Neuropathic Cancer Pain Linked to Reduced Quality of Life
- Dexamethasone-Induced Hiccups in Chemotherapy May be Prevented by Rotating to Methylprednisolone
- New Evidence Shows Metastases May Spread Independently of Lymph Nodes
- Long Term Survivors of Prostate Cancer Express Treatment Decision Regret for Up to 15 Years
- FDA Expands Clearance for Cooling Cap Use With Chemotherapy for Solid Tumors
- Recommendations for Vaccine Administration During Chemotherapy
- Risk for Prostate Cancer Not Associated With Vasectomy, Meta-analysis Affirms
- Disease-Free Survival After Breast Cancer Comparable With Exemestane, Sequential Tamoxifen/Exemestane
- Treating the Other "Patient": Depressive Symptoms Are Predictive of Declining Physical Health in Caregivers
- Oropharyngeal Mucositis Pain Effectively Relieved With Indomethacin Oral Spray
- Opioids Overprescribed in Patients Undergoing Surgery
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|